Skip to main content

Table 1 Patient and pharmacokinetic data for oseltamivir carboxylate in children receiving oral oseltamivir twice a day

From: Pharmacokinetics of oseltamivir in infants under the age of 1 year

Patient number

Age

months (m) and days (d)

Sex

Weight

(kg)

Dose

(mg/kg/dose)

Dose cycle

Cmax

(ng/mL)

Tmax

(h)

AUC0−t

(ng h/mL)

Time for AUC

(h)

No. plasma samples

1

6 m, 23 d

F

9.05

3

6

772

9.4

6376

0–9.4

5

2

5 m, 13 d

F

9.30

3

6

1960

5.8

18,816

0–10

5

3

11 m, 15 d

F

5.69

3

7

443

3.7

1747

3.7–6

2

4

3 m, 13 d

M

6.43

2.35

8

466

11.5

2156

5–11.5

2